Castration Resistant Prostate Cancer

Quantitative Analysis Of castration Resistant Prostate Cancer ...
RESEARCH ARTICLE Open Access Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling Reynald M Lescarbeau and David L Kaplan* ... Access Full Source

CASTRATION-RESISTANT PROSTATE CANCER
100 oncology • november 2014 emj european medical journal oncology • november 2014 emj european medical journal 101 state-of-the-art treatment in ... View Document

Leukapheresis - Wikipedia, The Free Encyclopedia
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. in the treatment of advanced breast cancer. [1] Another novel use of cells obtained through leukapheresis is to stimulate a patient’s immune system to target prostate cancer cells. [2 ... Read Article

Exelixis Finally Snags A Licensing Partner For Cometriq
Image source: Roche. ... Read News

MorphoSys AG Reports Results For Fiscal Year 2015
MARTINSRIED / MUNICH, Germany -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced financial results for the year ending December 31, 2015, as well as a financial and ... Read News

Issues Concerning Development Of Products For Treatment Of ...
1 Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting ... Document Viewer

Prostate Cancer Stem-like Cells Contribute To The Development ...
Review Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer Diane Ojo 1,2,3, Xiaozeng Lin 1,2,3, Nicholas Wong 1,2,3, Yan Gu 1,2,3 and Damu Tang 1,2,3,* ... Access Doc

Sequencing Of Agents In castration-resistant Prostate Cancer
Www.thelancet.com/oncology Vol 16 June 2015 e281 Review castration-resistant prostate cancer. Abiraterone acetate is a potent and irreversible inhibitor of cytochrome p450 ... Return Doc

Immunotherapy For castration-resistant Prostate Cancer ...
Urologic Oncology: Seminars and Original Investigations 33 (2015) 245–260 Review article Immunotherapy for castration-resistant prostate cancer: Progress and ... Retrieve Document

Nonmetastatic Castration-Resistant Prostate Cancer
Korean J Urol 2014;55:153-160 Nonmetastatic Castration-Resistant Prostate Cancer 155 TABLE 1. Key trials with new agents in nonmetastatic castration-resistant prostate cancer ... Fetch Document

Top 10 Reasons To Quit Smoking After A Diagnosis Of Cancer
Check out these 10 important reasons to quit smoking after a diagnosis of cancer. Smoking lowers survival, For men with prostate cancer metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: ... Read Article

Introduction And Overview Of Castration-Resistant Prostate ...
Moderator, Raoul S. Concepcion, MD, introduces a panel discussion focused on treatment challenges and practice management issues faced by oncologists and urologists who care for patients with prostate cancer. This discussion includes expert perspectives from Leonard G. Gomella, MD ... View Video

Treatment Advances In Metastatic Castration-Resistant ...
Castrate Resistant Prostate Cancer - 2013 Perspective by Prof Gavin Marx - Duration: 59:46. Evolution of Treatment for Metastatic Castration-Resistant Prostate Cancer - Duration: 6:16. OncLiveTV 150 views. 6:16 Loading more suggestions Show more. ... View Video

Castration-Resistant Prostate Cancer:Addressing Treatment ...
Castration-Resistant Prostate Cancer:Addressing Treatment Challenges, Managed Care Aspects, and Integration of Existing and New Therapies Into Practice ... Fetch Content

CHEMOTHERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
B1095 Recent Advances in Prostate Cancer CHEMOTHERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER Gopa Iyer, Howard I. Scher and David B. Solit INTRODUCTION ... Document Viewer

Treating Symptomatic Bone Metastatic Castration-Resistant ...
MD, discuss the mechanism of action and efficacy of radium-223, a novel agent for patients with castration-resistant prostate cancer. For more from this discussion, visit http://www.onclive.com/peer-exchange ... View Video

Treatment Patterns And Characteristics Of European Patients ...
RESEARCH ARTICLE Open Access Treatment patterns and characteristics of European patients with castration-resistant prostate cancer Cora N Sternberg1,5*, Edwina S Baskin-Bey2, Mark Watson2, Andrew Worsfold3, Alex Rider3 and Bertrand Tombal4 ... Return Doc

The New England Journal Medicine
Sipuleucel-T Therapy for Castration-Resistant Prostate Cancer n engl j med 363;5 nejm.org july 29, 2010 413 Randomization and Treatment Patients were randomly assigned in a 2:1 ratio to ... Access Full Source

The Hallmarks Of castration-resistant prostate cancers
Tumour Review The hallmarks of castration-resistant prostate cancers Maria Katsogiannou⇑,1, Hajer Ziouziou1, Sara Karaki, Claudia Andrieu, Marie Henry de Villeneuve, ... Fetch Document

Castration-Resistant Prostate Cancer - Springer
Abstract Until very recently, docetaxel was the only approved agent in castration-resistant prostate cancer (CRPC) and other effective therapeutic options are ... Doc Viewer

The 2015 CUA-CUOG Guidelines For The Management Of castration ...
Castration-resistant prostate cancer (CRPC) is defined by disease progression despite castrate levels of testosterone The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC) Summary ... View Full Source

Androgen-IndependentMolecularImagingVectorstoDetect ...
Castration-resistant prostate cancer (CRPC) progression will occur within an average of 12 to 18 months in the majority of thecases(1).DuetotheunfortunatelackofcureforCRPC,the search for more effective treatment and diagnostic regimen ... Fetch Doc

Cancer Identification Of EP4 As A Potential Target For The ...
Therapeutics, Targets, and Chemical Biology Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel ... Retrieve Full Source

PPP2R2C Loss Promotes castration-resistant Prostate Cancer ...
1 PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortality. Eric G. Bluemn1,2, E. Sophie Spencer1, Brigham Mecham2,3, Ryan R. Gordon2, Ilsa Coleman2, ... Document Viewer

castration-resistant Prostate Cancer - WOMEN IN MEDICINE LTD
Future science group www.futuremedicine.com 669 for prostate cancer. However, the addition of a GnRH agonist to abiraterone acetate resulted in a sustained decrease in both testosterone and ... Access Doc